跳至主要内容
临床试验/NCT04442633
NCT04442633已完成不适用

Clinical Evaluation of Glutamine Combined With Topical Corticosteroids in the Treatment of Erosive Oral Lichen Planus

Hams Hamed Abdelrahman1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Change in oral lichen planus lesions severity

研究概览

简要总结

Lichen planus (LP) is an inflammatory skin disease of unknown etiology. Glutamine promotes protein and collagen synthesis, imparts immunity, and maintains the alimentary canal mucosa structure.

详细描述

Lichen planus (LP) is an inflammatory skin disease of unknown etiology. Recently, increased oxidative stress has been implicated in the pathogenesis of erosive oral lichen planus (EOLP). Glutamine is a source of energy for fibroblasts, immunocompetent cells, and intestinal epithelial cells involved in collagen production. It promotes protein and collagen synthesis, imparts immunity, and maintains the alimentary canal mucosa structure.

The aim of this study is to evaluate the effect of Glutamine combined with topical corticosteroid in the treatment of oral erosive LP.

Thirty patients with a confirmed clinical and histopathologic diagnosis of OLP recruited in this study and divided into 2 equal groups, each consisting of 15 subjects. Group 1 consists of patients treated with topical steroids plus antifungal (conventional therapy); Group 2 consists of patients treated with Glutamine combined with topical steroids plus antifungal.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
30 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients clinically and histopathologically diagnosed to be suffering from EOLP.
  • Patients who had symptoms i.e. pain and/or burning sensation secondary to EOLP.
  • Patients under stressful life conditions as evidenced by ISMA-UK Stress Questionnaire
  • Males and Females with an age ranging from 30-60years

排除标准

  • Patients suspected to have a lichenoid drug reaction or lichenoid contact allergy.
  • Patients suffering from any systemic diseases (such as diabetes, cardiovascular, liver disorder, renal dysfunction)
  • Patients with findings of any physical or mental abnormality which would interfere with or be affected by the study procedure.

研究组 & 干预措施

conventional therapy

Active Comparator

topical corticosteroid plus antifungal

干预措施: Miconazole Oral gel (Drug)

conventional therapy

Active Comparator

topical corticosteroid plus antifungal

干预措施: Kenacort in orabase (Drug)

Glutamine with a topical corticosteroid plus antifungal

Experimental

Glutamine therapy in combination with a topical corticosteroid plus antifungal

干预措施: Glutamine Cap/Tab (Drug)

Glutamine with a topical corticosteroid plus antifungal

Experimental

Glutamine therapy in combination with a topical corticosteroid plus antifungal

干预措施: Miconazole Oral gel (Drug)

Glutamine with a topical corticosteroid plus antifungal

Experimental

Glutamine therapy in combination with a topical corticosteroid plus antifungal

干预措施: Kenacort in orabase (Drug)

结局指标

主要结局

Change in oral lichen planus lesions severity

时间窗: at baseline, 1 months and 3 months

Mucosal lesion severity score 0: no lesion score 1: white lesion score 2:atrophy/erosion intermixed or not with white lesion score 3: ulceration intermixed or not with white lesion

次要结局

  • Change in pain level(at baseline, 1 months and 3 months)

研究者

发起方
Hams Hamed Abdelrahman
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hams Hamed Abdelrahman

Assistant lecturer

Alexandria University

研究点 (1)

Loading locations...

相似试验